These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6653395)

  • 1. Treatment outcome in methadone detoxification: relationship to initial levels of illicit opiate use.
    Stitzer ML; McCaul ME; Bigelow GE; Liebson I
    Drug Alcohol Depend; 1983 Nov; 12(3):259-67. PubMed ID: 6653395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingency management interventions: effects on treatment outcome during methadone detoxification.
    McCaul ME; Stitzer ML; Bigelow GE; Liebson IA
    J Appl Behav Anal; 1984; 17(1):35-43. PubMed ID: 6725168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic opiate use during methadone detoxification: effects of a dose increase treatment.
    Stitzer ML; McCaul ME; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1984 Sep; 14(1):37-44. PubMed ID: 6489151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingent methadone delivery: effects on illicit-opiate use.
    Higgins ST; Stitzer ML; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1986 Jul; 17(4):311-22. PubMed ID: 3757767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification].
    Jovanović T; Lazarević D; Nikolić G
    Vojnosanit Pregl; 2012 Apr; 69(4):326-32. PubMed ID: 22624424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 21-day outpatient methadone detoxification: an evaluation.
    Kahn RB; Schramm NT; Martinez R; Joaquin J
    Int J Addict; 1976; 11(4):629-39. PubMed ID: 992917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of opiate drug abuse during a 90-day methadone detoxification.
    Iguchi MY; Stitzer ML
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):279-94. PubMed ID: 1928022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with relapse among opiate addicts in an out-patient detoxification programme.
    Unnithan S; Gossop M; Strang J
    Br J Psychiatry; 1992 Nov; 161():654-7. PubMed ID: 1422615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone maintenance and clonidine detoxification in the treatment of opiate addicts in Israel: suggesting evidence for cultural differences in the effectiveness of treatment modalities for opiate addiction.
    ShahamY ; Shufman ; Scher ; Barel ; Zlotogorski ; Cohen
    Isr J Psychiatry Relat Sci; 1991; 28(3):45-57. PubMed ID: 1666067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.
    Rhoades HM; Creson D; Elk R; Schmitz J; Grabowski J
    Am J Public Health; 1998 Jan; 88(1):34-9. PubMed ID: 9584030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting treatment dropouts from a drug abuse rehabilitation program.
    Craig RJ; Rogalski C; Veltri D
    Int J Addict; 1982 May; 17(4):641-53. PubMed ID: 7107090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients.
    Margolin A; Kantak K; Copenhaver M; Avants SK
    J Addict Dis; 2003; 22(2):49-61. PubMed ID: 12703668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of methadone maintenance in clinical opiate dependence].
    Gössling HW; Gunkel S; Wegener U; Woiton V
    Fortschr Neurol Psychiatr; 1998 Jun; 66(6):278-85. PubMed ID: 9676423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine in outpatient detoxification from methadone maintenance.
    Kleber HD; Riordan CE; Rounsaville B; Kosten T; Charney D; Gaspari J; Hogan I; O'Connor C
    Arch Gen Psychiatry; 1985 Apr; 42(4):391-4. PubMed ID: 3977557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728].
    Oldham NS; Wright NM; Adams CE; Sheard L; Tompkins CN
    BMC Fam Pract; 2004 Apr; 5():9. PubMed ID: 15117415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.